Successful treatment of a patient with NSCLC harboring an EGFR mutation and a concomitant Met Exon 14 skipping mutation combining Afatinib and Crizotinib - Kauffmann-Guerrero, D; Kahnert, K; Kumbrink, J; Syunyaeva, Z; Tufman, A; Huber, R M (Clin Lung Cancer, 2019)